2007
DOI: 10.1016/j.cca.2007.06.012
|View full text |Cite
|
Sign up to set email alerts
|

Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

3
35
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 33 publications
3
35
0
Order By: Relevance
“…PON1prevents lipid oxidation: not only of LDL, but also of HDL itself [17]. is protection is probably related to the PON1-hydrolysing activity of some activated phospholipids [18] and/or lipid peroxide [19] products. Human PON1 (aryldialkylphosphatase, EC 3.1.8.1) is a 43 kDa esterase associated with apolipoprotein A1 (apoA-I) and clusterin (apolipoprotein J) in HDL.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…PON1prevents lipid oxidation: not only of LDL, but also of HDL itself [17]. is protection is probably related to the PON1-hydrolysing activity of some activated phospholipids [18] and/or lipid peroxide [19] products. Human PON1 (aryldialkylphosphatase, EC 3.1.8.1) is a 43 kDa esterase associated with apolipoprotein A1 (apoA-I) and clusterin (apolipoprotein J) in HDL.…”
mentioning
confidence: 99%
“…Human PON1 (aryldialkylphosphatase, EC 3.1.8.1) is a 43 kDa esterase associated with apolipoprotein A1 (apoA-I) and clusterin (apolipoprotein J) in HDL. PON1 was shown to possess a peroxidase-like activity, which can contribute to its protective e ect against lipoprotein oxidation, as well as a homocysteinethiolactonase activity, which may be linked with its antiatherogenic properties [19,20].…”
mentioning
confidence: 99%
“…These findings may explain low PON1 activity in smokers and renal failure individuals (13)(14)(15)(16)(17)(18). Also, some studies have suggested that renal transplantation could decrease the risk of premature vascular aging by increase in PON activity and its anti-atherogenic properties (15)(16)(17)(18)(19). Treatment of CKD can increase PON activity and lower the risk of cardiovascular diseases in these patients.…”
mentioning
confidence: 99%
“…Previous studies showed that HD significantly restored PON1 activities. Moreover, an inverse association between PON1 activities recovery after HD was found with creatinine, advanced glycation end products and acrolein, suggesting that uremic toxins may play a mechanistic role in PON1 inactivation [23,24,39,40]. Another possible mechanism of diminished PON1 activity in HD patients involved Hcy a n d / o r i t s m e t a b o l i t e .…”
Section: Discussionmentioning
confidence: 99%
“…We found that serum PON1 lactonase activity was significantly decreased in HD patients compared with normal volunteers. Similarly, serum PON1 activities, including lactonase, were reported to be lower in end-stage renal disease patients undergoing HD compared with healthy controls [23][24][25]39,40]. A lower serum PON1 lactonase activity would be coupled with delayed catabolism of oxidized phospholipids in LDL and oxidized macrophages, and with greater protein homocysteinylation, accelerating atherogenesis [23,24].…”
Section: Discussionmentioning
confidence: 99%